AlphaCrest Capital Management LLC - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 229 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.52 and the average weighting 0.1%.

Quarter-by-quarter ownership
AlphaCrest Capital Management LLC ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$84,000
-2.3%
14,419
+25.4%
0.01%
+66.7%
Q4 2021$86,000
-9.5%
11,500
+9.2%
0.00%
-40.0%
Q3 2021$95,000
-76.4%
10,532
-68.6%
0.01%
-70.6%
Q2 2021$402,000
+74.8%
33,584
+83.2%
0.02%
+30.8%
Q1 2021$230,000
-60.6%
18,331
-51.0%
0.01%
-72.9%
Q4 2020$584,000
-53.0%
37,443
-71.5%
0.05%
-64.4%
Q3 2020$1,243,000
+347.1%
131,584
+324.5%
0.14%
+193.5%
Q2 2020$278,000
+227.1%
31,000
+203.9%
0.05%
+557.1%
Q4 2019$85,00010,2000.01%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Lombard Odier Asset Management (Switzerland) SA 1,539,994$11,550,0000.74%
Golden State Equity Partners 143,768$1,078,0000.54%
Rhenman & Partners Asset Management AB 765,000$5,975,0000.40%
WASATCH ADVISORS LP 10,960,982$82,207,0000.34%
KLK CAPITAL MANAGEMENT LLC 44,323$332,0000.32%
EMC Capital Management 61,394$460,0000.25%
Rokos Capital Management LLP 539,860$4,108,0000.25%
Long Focus Capital Management, LLC 245,000$1,838,0000.24%
Vanguard Capital Wealth Advisors 33,380$250,0000.18%
Fort Sheridan Advisors LLC 74,898$562,0000.16%
View complete list of SANGAMO THERAPEUTICS INC shareholders